TGF-β: From latent to active

Microbes and Infection

Volumn 1, Issue 15, 1999, Pages 1255-1263

  Khalil, Nasreen ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

L TGF ; Latency associated peptide; Reactive oxygen intermediate; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; CYTOKINE PRODUCTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SYNTHESIS REGULATION;

EID: 0033386176     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00259-2     Document Type: Review

References (74)

1. Lawrence D.A. Transforming growth factor β: a general review. Eur. Cytokine Netw. 7:1996;363-374.
2. Segarini P.R. TGF-β receptors: a complicated system of multiple binding proteins. Biochem. Biophys. Acta. 1155:1993;269-275.
3. Wrana J.L. TGF-β receptors and signaling mechanims. Miner Elect. Metab. 24:1998;120-130.
4. Gentry L., Nash B.W. The pro domain of pre-pro-transforming growth factor-β1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry. 90:1990;6851-6857.
5. Schulungger M., Grutter M.G. An unusual feature revealed by the crystal structure at 2, 2 angstrom resolution of transforming growth factor-β2. Nature. 358:1992;430-434.
6. Ten Dijke P., Iwata K.K., Thorikay M., Schwedes J., Stewart A., Piller C. Molecular characterization of transforming growth factor type β3. Ann. NY Acad. Sci. 593:1990;26-42.
7. Kanzaki T., Olofsson A., Moren A., Werastedt C., Hellman U., Miyazono K., Calaesson-Welsh L., Heldin C.H. TGF-β1 binding protein: A component of the large latent complex of TGF-β with multiple repeat sequences. Cell. 61:1990;1051-1061.
8. Moren A., Olofsson A., Stenman G., Sahbin P., Kanzaki T., Claesson-Welsh L., Ten Dijke P., Miyazona K., Heldin C.H. Identification and characterization of LTBP-2 a novel latent transforming growth factor-β-binding protein. J. Biol. Chem. 269:1994;32469-32478.
9. Yin W., Smiley E., Germiller J., Mecham R.P., Florer J.B., Wenstrup R.J., Bonadio J. Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J. Biol. Chem. 270:1995;10147-10160.
10. Brown P., Wakefield L., Levinson A., Spron M. Physiochemical activation of recombinant latent transforming growth factors-β's 123. Growth Factors. 3:1990;35-43.
11. Munger J.S., Harpel J.G., Gleizes P.E., Mazzieri R., Nunes I., Rifkin D.B. Latent transforming growth factor-β: Structural features and mechanisms of activation. Kid. Int. 51:1997;1376-1382.
12. Derynck R., Jarett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian K., Roberts A.B., Sporn M.B., Goeddel D.D. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
13. Blanchette F., Day R., Dong W., Laprise M.H. Dubois C, M, TGF-beta 1 regulates gene expression of its own converting enzyme furin. J. Clin. Invest. 99:1997;1974-1983.
14. Dubois C.M., Laprise M.H., Blanchette F., Gentry L.E., Leduc R. Processing transforming growth factor β1 precursor by human furin convertase. J. Biol. Chem. 270:1995;10618-10624.
15. Lopez A.R., Cook J., Deininger P.L., Derynk R. Dominant negative mutants of transforming growth factor-beta 1 inhibit the secretion of different transforming growth factor-beta isoforms. Mol. Cell Biol. 12:1992;1674-1679.
16. Purchio A., Cooper J.A., Brunner A.M., Lioubin M.N., Gentry L.E., Kovacina K.S., Roth R.A., Marguardt H. Identification of mannose-6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-β1 precursor. J. Biol. Chem. 263:1988;14211-14215.
17. Kavacina K., Steele P.G., Purchio A.F., Lioubin M., Mayazono K., Heldin C.H., Roth R.A. Interactions of recombinant and platelet transforming growth factor-β1 precursor with the insulin-like growth factor II/mannose-6-phosphate receptor. Biochem. Biophy. Res. Commun. 160:1989;393-403.
18. Brunner A.M., Marquardt H., Malacko A.R., Lioubin M.N., Purchio A.F. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor-β1 precursor, Expression and characterization of mutant proteins. J. Biol. Chem. 264:1989;13660-13664.
19. Saharinen J., Taipale J., Keski-Oja J. Association of small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1. EMBO J. 15:1996;245-253.
20. Miyazono K., Olofsson A., Colosetti P., Heldin C.H. A role of the latent TGF-β1 binding protein in the assembly and secretion of TGF-β1. EMBO J. 10:1991;1091-1101.
21. Taipale J., Miyazono K., Heldin C.H., Keski-Oja J. Latent transforming growth factor-b1 associates to fibroblast extracellular matrix via latent TGF-b binding protein. J. Cell Biol. 124:1994;171-181.
22. Khalil N., Corne S., Whitman C., Yacyshyn H. Plasmin regulates the activation of cell associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am. J. Respir. Cell Mol. Biol. 15:1996;252-259.
23. Miyazono K., Heldin C.H. Role for carbohydrate structures in TGF-beta 1 latency. Nature. 338:1989;158-160.
24. Schultz-Cherry S., Henshaw D.S. Influenza virus neuraminidase activates latent transforming growth factor beta. J. Virol. 70:1996;8624-8629.
25. Oursler M.J., Riggs B.L., Spelsberg T.C. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology. 133:1993;2187-2198.
26. Abe M., Oda N., Sato Y. Cell-associated activation of latent transforming growth factor-beta by calpain. J. Cell. Physiol. 174:1998;186-193.
27. Schultz-Cherry S., Chen H., Moser D., Misenheimer T.M., Krutzsch H.C., Roberts D.D., Murphy-Ullrich J.E. Regulation of transforming growth factor-β activation by discrete sequence of thrombospondin-1. J. Biol. Chem. 270:1995;7304-7310.
28. Allan E.H., Martin. The plasminogen activator inhibitor system in bone cell function. Clin. Osthop. Related Res. 313:1995;54-63.
29. Reuning U., Magdolen N., Wilhelm O., Fischer K., Lutz V., Graeff H., Schmitt M. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review). Int. J. Oncol. 13:1998;893-906.
30. Lyons R.M., Keski-Oja J., Moses H.L. Proteolytic activation of latent transforming growth factor-β fibroblast-conditioned media. J. Cell. Biol. 106:1988;1659-1665.
31. Vaughan D.E. Plasminogen activator inhibitor-1: a common denominator in cardiovascular disease. J. Investig. M. 46:1998;370-376.
32. Neville R.F., Sidaway A.N. Myointimal hyperplasia: basic science and clinical considerations. Semin. Vasc. Surg. 11:1998;142-148.
33. Nicosia R.F., Villaschi S. Autoregulation of angiogenesis by cells of the vessel wall. Int. Rev. Cytol. 185:1999;1-43.
34. Hirschi K.K., D'Amore P.A. Pericytes in the microvasculature. Cardiovasc. Res. 32:1996;687-698.
35. Antonelli-Orlidge A., Saunders K.B., Smith S.R., D'Amore P.A. An activated form of transforming growth factor β is produced by cocultures of endothethial cells and pericytes. Proc. Natl. Acad. Sci. USA. 86:1989;4544-4548.
36. Sato Y., Rifkin D.B. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of latent transforming growth factor-β1-like molecule by plasmin during co-culture. J. Cell. Biol. 109:1989;309-315.
37. Sato Y., Tsuboi R., Lyons R., Moses H., Rifkin D.B. Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self regulating system. J. Cell Biol. 3:1990;757-763.
38. Dennis P.A., Rifkin D.B. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose-6-phosphate/insulin like growth factor type II receptor. Proc. Natl. Acad. Sci. USA. 88:1991;580-584.
39. Nunes I., Gleizes P.E., Metz C.N., Rifkin D.B. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase dependent cross-linking of latent transforming growth factor-β J. Cell Biol. 136:1997;1151-1163.
40. Kojima S., Nara K., Rifkin D.B. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J. Cell Biol. 121:1993;439-448.
41. Flaumenhaft R., Abe M., Mignatti P., Rifkin D.B. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity. J. Cell Biol. 118:1992;901-909.
42. Yee J.A., Yan L., Dominquez J.C., Allane H., Martin T.J. Plasminogen-dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast-like cells. JOURNAL TITLE. 157:1993;528-534.
43. Friess H., Cantero D., Graber H., Tang W.H., Guo X., Kashiwagi M., Zimmermann A., Gold L., Korc M., Buchler M.W. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Gastroenterology. 113:1997;904-913.
44. Kagami S., Border W.A., Miller D.E., Noble N.A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93:1994;2431-2437.
45. Wolf G., Mueller E., Stahl R.A.K., Ziyadeh F.N. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β J. Clin. Invest. 92:1993;1366-1372.
46. Gibbons G.H., Pratt R.E., Dzau V.J. Vascular smooth muscle cell hypertrophy vs hyperplasia, Autocrine transforming growth factor-b1 expression determines growth response to angiotensin II. J. Clin. Invest. 90:1992;456-461.
47. Ziyadeh F.N., Sharma K., Ericksen M., Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β J. Clin. Invest. 93:1994;536-542.
48. Negrete H., Struder R.K., Craven P.A., Derubertis F.R. Role for transforming growth factor β in thromboxane-induced increases in mesangial cell fibronectin synthesis. Diabetes. 44:1995;335-339.
49. Riser B.L., Cortes P., Heilig C., Grondin J., Ladson-Wofford S., Patterson D., Narins R.G. Cyclic stretching force selectively up-regulates transforming growth factor-β isoforms in cultured rat mesangial cells. Am. J. Pathol. 148:1996;1915-1923.
50. Struder R.K., Negrete H., Craven P.A., Derubertis F.R. Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-β bioactivity in mesangial cells. Kid. Int. 48:1995;422-430.
51. Carmeliet P., Schoonjans L., Kleckens L., Ream B., Degen J., Bronson R., Devos R., VanDen Oor D.J., Colle N.D., Mulligan R.C. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:1994;419-424.
52. Carmeliet P., Moons L., Ploplis V., Plow E., Collen D. Impaired arterial neointim formation in mice with disruption of plasminogen gene. J. Clin. Invest. 99:1997;200-208.
53. Dewerchin M., Nuffelen A.V., Wallays G., Bouche A., Moons L., Carmeliet P., Mulligan R.C., Collen D. Generation and characterization of urokinase receptor-deficient mice. J. Clin. Invest. 97:1996;870-878.
54. Herbert J.M., Carmeliet P. Involvement of uPA in the anti-apoptotic activity of TGF-β for vascular smooth muscle cells. FEBS Let. 413:1997;401-404.
55. Kulkarani A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M.B., Ward J.M., Karlsson L. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 15:1993;770-774.
56. Harpel P.C., Hermann A., Zhany X., Ostfeld I., Borth W. Lipoprotein (a) plasmin modulation and atherogenesis. Thromb. Haemost. 74:1995;382-386.
57. Grainger D.J., Kemp P.R., Liu A.C., Lawn R.M., Metcalfe J.C. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein (a) mice. Nature. 370:1994;460-462.
58. Eitzman D.J., McCoy R.D., Zheng X., Fay W.P., Shen T., Ginsburg D. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or over express the murine plasminogen inhibitor-1 gene. J. Clin. Invest. 97:1996;232-237.
59. Tryggvason K., Hoyhtya M., Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochem. Biophys. Acta. 907:1987;191-217.
60. Adams J.C. Thrombospondin-1. Int. J. Biochem. Cell Biol. 29:1997;861-865.
61. Yehualaeshet T., O' Connor R., Green-Johnson J., Mai S., Silverstein R., Murphy-Ullrich J.E., Khalil N. Activation of rat alveolar macrophage derived L-TGF-β1 by plasmin requires interaction with TSP-1 and the TSP-1, Cell surface receptor CD36. Am. J. Pathol. 155:1999;841-855.
62. Crawford S.E., Stellmach N., Murphy-Ullrich J.E., Riberio S.M.F., Lawler J., Hynes R.O., Bowan G.P., Bouck N. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell. 93:1998;1159-1170.
63. Barcellos-Hoff M.H., Dix T.A. Redox-mediated activation of latent transforming growth factor-β1. Mol. Endocrinol. 10:1996;1077-1083.
64. Barcellos-Hoff M.H., Derynck R., Tsang M.L.S., Weatherbee J.A. Transforming growth factor-activation in irradiated murine mammary gland. J. Clin. Invest. 93:1994;892-899.
65. Barcellos-Hoff M.H., Ehrhart E.J., Kalia M., Jirtle R., Flanders K., Tsang M.L.S. Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am. J. Path. 147:1995;1228-1237.
66. Mathes S.J., Alexander J. Radiation of injury. Surg. Oncol. Clin. N. Am. 5:1996;809-824.
67. Nath K.A., Grande J., Croatt A., Haugen J., Kim Y., Rosenberg M.E. Redox regulation of renal DNA synthesis transforming growth factor-β1 and collagen gene expression. Kid. Int. 53:1998;367-381.
68. Chabot F., Mitchell J.A., Gutteridge J.M., Evans T.W. Reactive oxygen species in acute lung injury. Eur. Respir. J. 11:1998;745-757.
69. Hammerman C., Kaplan M. Ischemia & reperfusion injury, The ultimate pathophysiologic paradox. Clin. Perinatol. 25:1998;757-777.
70. Novelli G.P. Role of free radicals in septic shock. J. Physiol. Pharmacol. 48:1997;517-527.
71. Munger J.S., Huang X., Kawakatsu H., Griffiths M., Dalton J.D., Wu S.L., Pittet J., Kaminski J.F., Garat C., Mathay M.A., Rifkin D.B., Sheppard D. The integrin αVβ6 binds and activates latent TGF-β1: A mechanism for regulation of pulmonary inflammation and fibrosis. Cell. 96:1999;319-328.
72. Barral A., Barral-Netto M., Yong E.C., Brownell C.E., Twardzik D.R., Reed S.G. Transforming growth factor β as a virulence mechanism for Leishmania Braziliensis. Proc. Natl. Acad. Sci. USA. 90:1993;3442-3446.
73. Miyazono K., Ichijo H., Heldin C.H. Transforming growth factor-beta: latent forms binding proteins and receptors. Growth Factors. 8:1993;11-12.
74. Douglas D., O'Connor R., Parekh T., Samuel S., Gold L., Khalil N. Altered expression of transforming growth factor-β type I and II receptors on the rat alveolar epithelium during bleomycin-induced lung injury. Am. J. Crit. Care M. 155:1997;A829.